Open AccessWeekly Cyclophosphamide-Bortezomib-Dexamethasone Induction Performs Comparably to Twice-Weekly Dosing with Respect to Both Response Rates and Survival after Autologous Transplant
Author(s) -
Caitlin Thirunavukarasu,
N Weber,
Kirk Morris,
Elango Pillai,
Cameron Curley,
Jason Butler,
Glen Kennedy
Publication year - 2019
Publication title -
acta haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.574
H-Index - 56
eISSN - 1421-9662
pISSN - 0001-5792
DOI - 10.1159/000501791
Subject(s) - dexamethasone , cyclophosphamide , dosing , medicine , bortezomib , induction therapy , oncology , pharmacology , multiple myeloma , chemotherapy